HHS Relaxed Clinical Trial Disclosure Rule Invalid

February 25, 2020

Health and Human Services Department (HHS) unlawfully adopted a final rule that allows drugmakers to avoid disclosing certain information about clinical trials completed between 2007 and 2017 on products approved by Food and Drug Administration (FDA), a federal court in New York said.